Expected earnings - Knight Therapeutics Inc.
Source: Canadian Earnings Reports
Knight Therapeutics Inc. (GUD:CA) is expected to report $0.03 for Q2 2025
Knight Therapeutics Inc.
NASDAQ: GUD:CC
GUD:CC Trading
-4.46% G/L:
$5.57 Last:
163,115 Volume:
$5.83 Open:
GUD:CC Latest News
February 18, 2026 07:30:00 am
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil
December 18, 2025 07:30:00 am
Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris
